These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Comparison of intravenous anisoylated plasminogen streptokinase activator complex and intracoronary streptokinase in acute myocardial infarction. Bonnier HJ; Visser RF; Klomps HC; Hoffmann HJ Am J Cardiol; 1988 Jul; 62(1):25-30. PubMed ID: 3289357 [TBL] [Abstract][Full Text] [Related]
4. An interim report of the efficacy and safety of anisoylated plasminogen streptokinase activator complex (APSAC). Johnson ES; Cregeen RJ Drugs; 1987; 33 Suppl 3():298-311. PubMed ID: 3315612 [TBL] [Abstract][Full Text] [Related]
5. Reperfusion in acute myocardial infarction. A multicentre randomised trial of early intracoronary streptokinase and intravenous anisoylated plasminogen streptokinase activator complex in the United States. Anderson JL Drugs; 1987; 33 Suppl 3():154-62. PubMed ID: 3315584 [TBL] [Abstract][Full Text] [Related]
6. New developments in thrombolytic therapy. Collen D; Gold HK Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372 [TBL] [Abstract][Full Text] [Related]
7. Comparison of intravenous anisoylated plasminogen streptokinase activator complex with intracoronary streptokinase in acute myocardial infarction. Bonnier JJ Drugs; 1987; 33 Suppl 3():151-3. PubMed ID: 3315583 [TBL] [Abstract][Full Text] [Related]
9. Summary of early clinical experience with anisoylated plasminogen streptokinase activator complex in the treatment of acute myocardial infarction. Jackson D Drugs; 1987; 33 Suppl 3():104-11. PubMed ID: 3315574 [TBL] [Abstract][Full Text] [Related]
10. Electrocardiographic and enzymatic infarct size in a randomised study of intracoronary streptokinase and intravenous anisoylated plasminogen streptokinase activator complex in acute myocardial infarction. Hackworthy RA; Sorensen SG; Menlove RL; Anderson JL Drugs; 1987; 33 Suppl 3():198-208. PubMed ID: 3315592 [TBL] [Abstract][Full Text] [Related]
11. Early clinical evaluation of the intravenous treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex. Kasper W; Meinertz T; Wollschläger H; Bonzel T; Chen C; Hofmann T; Zeiher A; Drexler H; Just H Drugs; 1987; 33 Suppl 3():112-6. PubMed ID: 3315575 [TBL] [Abstract][Full Text] [Related]
12. The effect of thrombolytic therapy with anisoylated plasminogen streptokinase activator complex on the indicators of myocardial salvage. Buchalter MB; Bourke JP; Jennings K; Adams PC; Kenmure AC; Hah CW; Reid DS Drugs; 1987; 33 Suppl 3():209-15. PubMed ID: 3315593 [TBL] [Abstract][Full Text] [Related]
13. Anisoylated plasminogen streptokinase activator complex (APSAC). A review of its mechanism of action, clinical pharmacology and therapeutic use in acute myocardial infarction. Monk JP; Heel RC Drugs; 1987 Jul; 34(1):25-49. PubMed ID: 3308411 [TBL] [Abstract][Full Text] [Related]
14. Dose-ranging studies of anisoylated plasminogen streptokinase activator complex. Studies in healthy volunteers and in patients with acute myocardial infarction. Marder VJ; Rothbard RL; Fitzpatrick PG; Francis CW; Norry EC Drugs; 1987; 33 Suppl 3():124-32. PubMed ID: 3315577 [TBL] [Abstract][Full Text] [Related]